Publikacijos

Ziaunys M., Sneideris T., Smirnovas V. (2018) Self-inhibition of insulin amyloid-like aggregation. Physical Chemistry Chemical Physics, vol. 20, no. 43, pp. 27638–27645. doi: 10.1039/C8CP04838J

Iashchishyn A., Sulskis D, Nguyen Ngoc M, Smirnovas V, Morozova-Roche LA (2017) Finke–Watzky Two-Step Nucleation–Autocatalysis Model of S100A9 Amyloid Formation: Protein Misfolding as ‘Nucleation’ Event. ACS Chemical Neuroscience 8 (10), pp 2152–2158. doi: 10.1021/acschemneuro.7b00251

Šneideris T, Baranauskienė L, Cannon JG, Rutkienė R, Meškys R, Smirnovas V (2015) Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives. PeerJ 3:e1271 . doi: 10.7717/peerj.1271

Sneideris T, Milto K, Smirnovas V (2015) Polymorphism of amyloid-like fibrils can be defined by the concentration of seeds. PeerJ 3:e1207 . doi: 10.7717/peerj.1207

Sneideris T, Darguzis D, Botyriute A, Grigaliunas M, Winter R, Smirnovas V (2015) pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils. PloS One 10:e0136602 . doi: 10.1371/journal.pone.0136602

Malisauskas R, Botyriute A, Cannon JG, Smirnovas V (2015) Flavone derivatives as inhibitors of insulin amyloid-like fibril formation. PloS One 10:e0121231 . doi: 10.1371/journal.pone.0121231

Milto K, Michailova K, Smirnovas V (2014) Elongation of mouse prion protein amyloid-like fibrils: Effect of temperature and denaturant concentration. PLoS One 9:e94469 . doi: 10.1371/journal.pone.0094469

Milto K, Botyriute A, Smirnovas V (2013) Amyloid-Like Fibril Elongation Follows Michaelis-Menten Kinetics. PLoS One 8:e68684 . doi: 10.1371/journal.pone.0068684